Breakout Stocks of Week 17 @ SZCE
NASDAQ fell hard last week and was down all -5.52% ending at 15,282.01 points after ending the week prior at 16,175.09 points. The sharp fall could pose a good buying opportunity. Our system has detected some possible breakout stocks for the following week and these should be on your watchlist. These are the stocks that are bouncing up with good increase in volume and are likely to do good in short term. One of these stocks are Guoyuan Securities Company Limited SZCE:000728. This stock has had a buy signal since Apr 17, 2024 when the price was ¥6.46 , but have so far fallen -0.310% to ¥6.44. Some other companies are on our watchlist to, among these are Fujian Sunner Development Co Ltd SZCE:002299 Vats Liquor Chain Store Management JSC SZCE:300755 Jiangsu Yanghe Brewery JSC Ltd. SZCE:002304 and Hualan Biological Engineering Inc SZCE:002007 which all got a breakout pattern emerging.
| Date | Company | Price | Week 17 |
|---|---|---|---|
| Guoyuan Securities Company Limited | ¥6.44 | ¥6.79 | 5.43% |
| Fujian Sunner Development Co Ltd | ¥15.50 | ¥14.90 | -3.87% |
| Vats Liquor Chain Store Management Jsc | ¥16.28 | ¥17.85 | 9.64% |
| Jiangsu Yanghe Brewery Jsc Ltd. | ¥95.45 | ¥100.09 | 4.86% |
| Hualan Biological Engineering Inc | ¥19.03 | ¥18.54 | -2.57% |
The Guoyuan Securities Company Limited stock price fell by -0.770% on the last day (Friday, 19th Apr 2024) from ¥6.49 to ¥6.44. During the last trading day the stock fluctuated 1.56% from a day low at ¥6.43 to a day high of ¥6.53. The price has been going up and down for this period, and there has been a -3.3% loss for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -11 million shares and in total, 30 million shares were bought and sold for approximately ¥195.79 million.
Several short-term signals are positive and we conclude that the current level may hold a buying opportunity, as there is a fair chance for Guoyuan Securities Company Limited stock to perform well in the short-term period.
About Guoyuan Securities Company Limited:
Guoyuan Securities Company Limited operates as a securities brokerage company in China. The company offers retail brokerage, investment banking and management, credit, asset management, Internet financial, research consulting, integrated private equity, futures, private equity investment, and public fund management services. Guoyuan Securities Company Limited was founded in 2001 and is based in Hefei, China.
The Fujian Sunner Development Co Ltd stock price fell by -0.768% on the last day (Friday, 19th Apr 2024) from ¥15.62 to ¥15.50. During the last trading day the stock fluctuated 2.28% from a day low at ¥15.36 to a day high of ¥15.71. The price has fallen in 7 of the last 10 days and is down by -7.57% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -4 million shares and in total, 6 million shares were bought and sold for approximately ¥98.37 million.
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Fujian Sunner Development Co Ltd stock to perform well in the short-term.
About Fujian Sunner Development Co Ltd:
Fujian Sunner Development Co., Ltd. engages in breeding, slaughtering, processing, and selling of chicken products in China. It also offers divided chilled/frozen chicken and deep processed meat products. The company was founded in 1983 and is headquartered in Nanping, China.
The Vats Liquor Chain Store Management JSC stock price fell by -0.732% on the last day (Friday, 19th Apr 2024) from ¥16.40 to ¥16.28. During the last trading day the stock fluctuated 5.85% from a day low at ¥16.06 to a day high of ¥17.00. The price has fallen in 6 of the last 10 days and is down by -5.4% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -1 million shares and in total, 1 million shares were bought and sold for approximately ¥23.04 million.
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Vats Liquor Chain Store Management JSC stock to perform well in the short-term.
About Vats Liquor Chain Store Management JSC:
VATS Liquor Chain Store Management Joint Stock Co., Ltd. operates a chain of liquor stores in China. It distributes domestic and international wines and alcohol products. The company was founded in 2005 and is headquartered in Beijing, China.
The Jiangsu Yanghe Brewery JSC Ltd. stock price fell by -1.27% on the last day (Friday, 19th Apr 2024) from ¥96.68 to ¥95.45. During the last trading day the stock fluctuated 2.19% from a day low at ¥94.90 to a day high of ¥96.98. The price has fallen in 6 of the last 10 days and is down by -4.53% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -2 million shares and in total, 3 million shares were bought and sold for approximately ¥330.79 million.
Jiangsu Yanghe Brewery JSC Ltd. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
About Jiangsu Yanghe Brewery JSC Ltd.:
Jiangsu Yanghe Brewery Joint-Stock Co., Ltd. produces, packages, and sells liquors, wines, and spirits. It offers its products primarily under the Yanghe and Shuanggou brands. The company was founded in 2002 and is headquartered in Suqian, China.
The Hualan Biological Engineering Inc stock price gained 0.528% on the last trading day (Friday, 19th Apr 2024), rising from ¥18.93 to ¥19.03. During the last trading day the stock fluctuated 2.09% from a day low at ¥18.70 to a day high of ¥19.09. The price has been going up and down for this period, and there has been a -2.11% loss for the last 2 weeks. Volume fell on the last day by -5 million shares and in total, 9 million shares were bought and sold for approximately ¥172.89 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
Hualan Biological Engineering Inc holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
About Hualan Biological Engineering Inc:
Hualan Biological Engineering Inc., a biopharmaceutical company, researches, develops, produces, and commercializes plasma products, viral vaccines, bacterial vaccines, and recombinant proteins and other biologics in the People's Republic of China. Its blood products comprise human albumin, human immunoglobulin, intravenous human immunoglobulin, rabies immunoglobulin, hepatitis B human immunoglobulin, tetanus human immunoglobulin, human prothrombin complex, human coagulation factor VIII, lyophilized human thrombin for external use, freeze-dried human fibrin glue for surgery, and human fibrinogen. The company's vaccines consist of influenza virus split vaccine, recombinant hepatitis B vaccine, ACYW135 meningococcal polysaccharide vaccine, A H1N1 influenza virus split vaccine, and quadrivalent influenza virus split vaccine. The company has strategic alliance with the Chinese Academy of Sciences, and other scientific research institutes and scientific research companies. The company was founded in 1992 and is based in Xinxiang, the People's Republic of China.
Despite these candidates are looking good from a technical perspective they may not perform as expected. You should always be cautious when trading and base your decisions on more than one source of information. This does not constitute an offer or recommendation to buy or sell securities.
